Semaglutide: all 426 studies that test it

Page 4 of 5. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.

• Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMActive, not recruitingNCT06005012Phase 2
• A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy ParticipantsCompletedNCT05996874Phase 1
• A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose WeightCompletedNCT05996848Phase 3
• Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion TherapiesCompletedNCT05920889Phase 2
• Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?CompletedNCT05895643Phase 2
• Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)CompletedNCT05892432Phase 2
• Semaglutide Therapy for Alcohol Reduction - TulsaCompletedNCT05891587Phase 2
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)CompletedNCT05890976Phase 3
• Novel Therapeutics and Endothelial Dysfunction in T1DM PatientsCompletedNCT05857085Phase 4
• Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial HyperplasiaWithdrawnNCT05829460Phase 2
• A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes MellitusCompletedNCT05816057Phase 3
• Semaglutide in Nonalcoholic Fatty Liver DiseaseCompletedNCT05813249Phase 4
• A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy ParticipantsCompletedNCT05784402Phase 1
• A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedNCT05766709Phase 1
• A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906CompletedNCT05751226Phase 1
• A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightActive, not recruitingNCT05726227Phase 3
• A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) DoseCompletedNCT05689099Phase 1
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsActive, not recruitingNCT05669755Phase 3
• Comparison of Body Weight Change Through Different Smeglutide Administration MethodsStatus unknownNCT05616052Phase 4
• Glucagon-like Peptide-1 Agonism With Very Low Calorie DietsStatus unknownNCT05606471Phase 4
• Young Adults With Early-onset Obesity Treated With SemaglutideCompletedNCT05574439Phase 4
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightActive, not recruitingNCT05567796Phase 3
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese MenCompletedNCT05498610Phase 1
• Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and ObesityWithdrawnNCT05444153Phase 3
• Efficacy of Oral Semaglutide in Overweight or ObesityStatus unknownNCT05442450Phase 4
• A Study of Cardiovascular Events iN Diabetes PlusActive, not recruitingNCT05441267Phase 4
• A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherCompletedNCT05435677Phase 1
• A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One TabletCompletedNCT05429593Phase 1
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightCompletedNCT05394519Phase 3
• Obesity Treatment to Improve DiabetesCompletedNCT05390307Not applicable
• Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection FractionCompletedNCT05371496Phase 4
• Semaglutide in Comorbid Schizophrenia Spectrum Disorder and ObesityActive, not recruitingNCT05333003Not applicable
• Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 DiabetesCompletedNCT05303857Phase 4
• Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)Active, not recruitingNCT05254314Phase 2
• "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."Status unknownNCT05249881Early Phase 1
• A Clinical Trial Looking at the Comparability of 2 Different Forms of SemaglutideCompletedNCT05232708Phase 1
• Semaglutide to Reduce Atrial Fibrillation BurdenSuspendedNCT05209165Phase 4
• A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the LiverActive, not recruitingNCT05202353Phase 1
• Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related PrediabetesCompletedNCT05193578Phase 2
• A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After MenopauseCompletedNCT05153564Phase 1
• Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes PatientsStatus unknownNCT05147896Not applicable
• Latino Semaglutide StudyCompletedNCT05087342Phase 3
• The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 DiabetesCompletedNCT05078255Not applicable
• Semaglutide 2.4 mg in Patients With Poor Weight-lossActive, not recruitingNCT05073835Phase 3
• Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver DiseaseActive, not recruitingNCT05067621Phase 2
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)CompletedNCT05016882Phase 2
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedNCT05013229Phase 3
• Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)CompletedNCT04979130Phase 4
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityCompletedNCT04940078Phase 1
• Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle CareTerminatedNCT04938388Phase 4
• Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesCompletedNCT04916470Phase 3
• Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?Active, not recruitingNCT04892199Phase 4
• SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without DiabetesCompletedNCT04889183Phase 3
• Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF PatientsWithdrawnNCT04885634Phase 3
• A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese MenCompletedNCT04878406Phase 1
• The Effect of Semaglutide on Pituitary FunctionCompletedNCT04865744Phase 4
• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)Active, not recruitingNCT04822181Phase 3
• A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide TabletsCompletedNCT04817644Phase 1
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)CompletedNCT04777409Phase 3
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)CompletedNCT04777396Phase 3
• The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone FractureStatus unknownNCT04702516Phase 1/2
• Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19Status unknownNCT04615871Phase 2
• Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy PeopleCompletedNCT04524832Phase 1
• A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different TimesCompletedNCT04513704Phase 1
• Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive DisorderCompletedNCT04466345Phase 2
• Semaglutide and Dapagliflozin in Diabetic Patients With Different PathophysiologyActive, not recruitingNCT04451837Phase 2
• 16-week Flexible vs. 8-week Semaglutide TitrationStatus unknownNCT04447859Phase 3
• Exercise and GLP-1 RA on Insulin SecretionStatus unknownNCT04383197Not applicable
• SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 DiabetesWithdrawnNCT04287179Phase 3
• The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and ObesityCompletedNCT04263415Phase 4
• First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With DiabetesCompletedNCT04259801Phase 1
• A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection PensCompletedNCT04238962Phase 1
• A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of SemaglutideCompletedNCT04228354Phase 1
• A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityCompletedNCT04187300Phase 1
• A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection PensCompletedNCT04152915Phase 1
• A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide TabletsCompletedNCT04109508Phase 1
• A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide TabletsCompletedNCT04097600Phase 1
• Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and AlbuminuriaStatus unknownNCT04061200Phase 4
• A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 DiabetesCompletedNCT04032197Phase 1
• A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are ChineseCompletedNCT04016974Phase 1
• A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityTerminatedNCT04012255Phase 1
• Semaglutide Treatment On Coronary ProgressionCompletedNCT03985384Phase 4
• Triple Therapy in T1DMActive, not recruitingNCT03899402Phase 2/3
• A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With ObesityCompletedNCT03842202Phase 1
• A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesActive, not recruitingNCT03811561Phase 3
• A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or TogetherCompletedNCT03789578Phase 1
• A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or ObeseCompletedNCT03707990Phase 1
• GLP1R in Parkinson's DiseaseStatus unknownNCT03659682Phase 2
• A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection ToolsCompletedNCT03598621Phase 1
• A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or ObeseCompletedNCT03574584Phase 1
• A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the LiverCompletedNCT03357380Phase 1
• Once Weekly GLP-1 in Persons With Spinal Cord InjuryCompletedNCT03292315Phase 4
• A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese SubjectsCompletedNCT03288740Phase 1
• Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male SubjectsCompletedNCT03144271Phase 1
• A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy SubjectsCompletedNCT03010475Phase 1
• A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.CompletedNCT02920385Phase 1
• Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.CompletedNCT02877355Phase 1
• A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal FemalesCompletedNCT02845219Phase 1
• A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 DiabetesCompletedNCT02773381Phase 1
• Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once WeeklyCompletedNCT02557620Phase 1

← Semaglutide overview